Question 1

What are the potential benefits of participating in this trial for my pancreatic cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 2

How will NMK89 help in my treatment or imaging process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of NMK89?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience any adverse effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options available that I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer clinical trial (NCT06129422). Contact the study team or your healthcare provider for specific answers.

What this study is about